Notícias e Atividades da Fujifilm Cellular Dynamics

A Fujifilm Cellular Dynamics pertence à Fujifilm Holdings.

Fujifilm Holdings é uma das ...

• Forbes Global 2000 (#614);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Fujifilm Holdings é uma empresa listada sob o símbolo 4901 (JP).

Fujifilm Holdings tem presença direta em 10 países.

Fujifilm Holdings possui 18 subsidiárias incluindo Astra Graphia, Fujifilm e Fujifilm Biotechnologies.

Eles estão dentro:

• Equipamento de Escritório26%
• Equipamentos Médicos16%
• Outro58%

Veja o organograma con seus 5 executivos principais

Biografias mais buscadas da Fujifilm Cellular Dynamics

• Seimi Satake, Chief Executive Officer and Chairman of the Board
• David Bolish, Chief Operating Officer
• Delara Motlagh, President

Recentes movimentos de executivos em Fujifilm Cellular Dynamics

• Delara Motlagh antes Chief Operating Officer, agora é President  (Notícia publicada em 5 de junho de 2026).
• David Bolish, ingressou na Companhia como Chief Operating Officer  (Notícia publicada em 5 de junho de 2026).

Criar um alerta
para seguir os movimentos de executivos da Fujifilm Cellular Dynamics.

Fujifilm Holdings possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado em 15 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Patrick Enright - Director da CuraSen Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Fujifilm Cellular Dynamics

• FUJIFILM Cellular Dynamics Announces the Appointment of Dr. Ilyas Singeç as Chief Scientific Officer | Fujifilm [United States]
• FUJIFILM Cellular Dynamics Launches Parkinson’s Disease iCell DopaNeurons Featuring LRRK2 and GBA Mutations
• Fujifilm Agrees on Core Terms with Australian Regenerative Medicine Venture Cynata to Manufacture Cynata’s iPS Cell-Derived Regenerative Medicine Products
• FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process
• Cynata and FUJIFILM Cellular Dynamics Execute Strategic Manufacturing Agreement | FujiFilm CDI
• Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay Development
• iCell Cardiomyocytes², 01434, GCM201434 | FujiFilm CDI
• BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases | FujiFilm CDI
• Search results for: 'news item fujifilm cellular dynamics and sana biotechnology announce license agreement for the development of ipsc derived cell' | FujiFilm CDI
• FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies | FujiFilm CDI
• View more press releases Close

Redes sociais sobre Fujifilm Cellular Dynamics

• Fujifilm Cellular Dynamics na Wikipedia, Google News e Yahoo Finance
• Fujifilm Cellular Dynamics na LinkedIn, X (Twitter) e YouTube